These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Awareness of indications for device therapy among a broad range of physicians: a survey study. Hübinette C; Lund LH; Gadler F; Ståhlberg M Europace; 2014 Nov; 16(11):1580-6. PubMed ID: 24451291 [TBL] [Abstract][Full Text] [Related]
4. Cardiac defibrillation and resynchronization therapies: principles, therapies, and management implications. Bubien RS; Ching EA; Kay GN AACN Clin Issues; 2004; 15(3):340-61. PubMed ID: 15475810 [TBL] [Abstract][Full Text] [Related]
5. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block. Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V; J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205 [TBL] [Abstract][Full Text] [Related]
6. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry. Gadler F; Valzania C; Linde C Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667 [TBL] [Abstract][Full Text] [Related]
7. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy. Soliman OI; Theuns DA; van Dalen BM; Vletter WB; Nemes A; Jordaens LJ; Balk AH; Ten Cate FJ; Geleijnse ML Am J Cardiol; 2010 Jan; 105(1):105-11. PubMed ID: 20102900 [TBL] [Abstract][Full Text] [Related]
8. Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator. Daubert JC; Leclercq C; Mabo P Europace; 2009 Nov; 11 Suppl 5():v87-92. PubMed ID: 19861397 [TBL] [Abstract][Full Text] [Related]
10. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy. Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019 [TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial. Merkely B; Kosztin A; Roka A; Geller L; Zima E; Kovacs A; Boros AM; Klein H; Wranicz JK; Hindricks G; Clemens M; Duray GZ; Moss AJ; Goldenberg I; Kutyifa V Europace; 2017 Sep; 19(9):1549-1555. PubMed ID: 28339581 [TBL] [Abstract][Full Text] [Related]
12. Resynchronization therapy is an important advance in the management of congestive heart failure: view of an antagonist. Jessup M J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S30-4. PubMed ID: 12950515 [TBL] [Abstract][Full Text] [Related]
13. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association. Raatikainen MJ; Arnar DO; Merkely B; Camm AJ; Hindricks G Europace; 2016 Aug; 18 Suppl 3():iii1-iii79. PubMed ID: 27496955 [TBL] [Abstract][Full Text] [Related]
14. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study. Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833 [TBL] [Abstract][Full Text] [Related]
15. Is implantable defibrillator indicated in all patients on cardiac resynchronization therapy? Pieragnoli P; Ricciardi G; Colella A; Musilli N; Porciani MC; Giaccardi M; Padeletti L; Michelucci A Minerva Cardioangiol; 2006 Dec; 54(6):735-41. PubMed ID: 17167385 [TBL] [Abstract][Full Text] [Related]
16. [Cardiac resynchronization therapy with or without defibrillation backup: everything has been written?]. Botto GL; Luzi M; Russo G; Mariconti B G Ital Cardiol (Rome); 2010 Apr; 11(4):306-9. PubMed ID: 20677576 [No Abstract] [Full Text] [Related]
17. Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator. Kramer DB; Normand ST; Volya R; Hatfield LA Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004763. PubMed ID: 30562069 [TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry. Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF; Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396 [TBL] [Abstract][Full Text] [Related]
19. Cardiac-resynchronization therapy for the prevention of heart-failure events. Moss AJ; Hall WJ; Cannom DS; Klein H; Brown MW; Daubert JP; Estes NA; Foster E; Greenberg H; Higgins SL; Pfeffer MA; Solomon SD; Wilber D; Zareba W; N Engl J Med; 2009 Oct; 361(14):1329-38. PubMed ID: 19723701 [TBL] [Abstract][Full Text] [Related]